Alex Delaney-Gesing 

home

authors

alex-delaney-gesing


Susan Coultas, PhD (top left), and Preeya Gupta, MD (bottom, middle) , discuss Kala Pharmaceuticals’ dry eye product candidate in a poster presentation—“Safety and Efficacy of KPI-121 0.25% for the Short-Term Treatment of Signs and Symptoms of Dry Eye Disease in Three Large Multicenter Randomized Controlled Trials”—during the 2020 Women in Ophthalmology virtual summer symposium with Sheryl Stevenson, group editorial director, 

Videos

Susan Coultas, PhD, and Preeya Gupta, MD, discuss Kala Pharmaceuticals’ dry eye product candidate in a poster presentation during the 2020 Women in Ophthalmology virtual summer symposium.

Kala’s dry eye treatment nears potential US launch before 2021

In this fourth installment on "2020 vision," pharmaceutical representatives share their outlook on what lies ahead for glaucoma innovations within the ophthalmic space. 

Featured: Chris Adams, Diopter Corp (CEO); Daria Lemann-Blumenthal, BELKIN Laser Ltd (CEO); Victor Chan, MB, MS, director of U.S. Surgical Device Commercial Marketing (Santen, Inc)
Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline (Allergan).



​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 


2020 vision: What is the future of ophthalmology?



2020 vision: The future of ophthalmology (Part II)



2020 vision: The future of ophthalmology (Part III) 

In this fourth installment on "2020 vision," pharmaceutical representatives share their outlook on what lies ahead for glaucoma innovations within the ophthalmic space.  

2020 vision: The future of ophthalmology (Part IV)

Susan Coultas, PhD (top left), and Preeya Gupta, MD (bottom, middle) speak with 

®' Sheryl Stevenson on their hope for continued innovation in the ophthalmic space — including dry eye and retina — as well as the importance of the clinical research process.

Watch the first two installments of this video series here:



2020 vision: What is the future of ophthalmology?

Susan Coultas, PhD, and Preeya Gupta, MD, share their hopes for continued innovation in the ophthalmic space  — including dry eye and retina — as well as the importance of the clinical research process.

2020 vision: The future of ophthalmology (Part III)

S.K. Steven Houston III, MD, speaks with 

' Sheryl Stevenson on how his practice has put to use recent retina innovations and adapted to accommodate the ever-changing operating room spacing and set-up in the current 

Watch Dr. Houston's interview from the virtual 2020 ASRS meeting on how his retina practice has utilized the NGENUITY 1.4 upgrade from Alcon

Podcasts


S.K. Steven Houston III, MD, shares how his practice has put to use recent retina innovations and adapted to accommodate the ever-changing operating room spacing and set-up in the current COVID-19 environment.

Author | Alex Delaney-Gesing

Articles

2020 vision: The future of ophthalmology (Part IV)

2020 vision: The future of ophthalmology (Part III)

Putting to practice retina innovations amid a pandemic

Kala’s dry eye treatment nears potential US launch before 2021